Patent: 10,265,374
✉ Email this page to a colleague
Summary for Patent: 10,265,374
Title: | Occidiofungin formations and uses thereof |
Abstract: | Disclosed are occidiofungin formulations and uses thereof for the treatment of proliferative disorders, such as cancer. Methods of producing the disclosed occidiofungin formulations are also provided. Further, methods of treating a subject with the formulations are provided. In some embodiments, the formulations include occidiofungin and one or more cyclodextrins. The formulations may optionally further comprise an additional chemotherapeutic agent for treating the proliferative disease, lipid vesicles, and/or aqueous solvents (including pharmaceutically acceptable buffers and/or exceipients). |
Inventor(s): | Smith; James L. (College Station, TX), Pruett; Stephen (Starkville, MS), Austin; Frank (Starkville, MS), Lu; Shien (Starkville, MS), Akshaya; Ravichandran (Bryan, TX), Laihing; Steven (College Station, TX) |
Assignee: | MISSISSIPPI STATE UNIVERSITY (Starkville, MS) THE TEXAS A&M UNIVERSITY SYSTEM (College Station, TX) |
Application Number: | 15/510,801 |
Patent Claims: | see list of patent claims |
Details for Patent 10,265,374
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Microbix Biosystems Inc. | KINLYTIC | urokinase | For Injection | 021846 | 01/16/1978 | ⤷ Try a Trial | 2034-09-12 |
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2034-09-12 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2034-09-12 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2034-09-12 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2034-09-12 | |
Hoffmann-la Roche Inc. | ROFERON-A | interferon alfa-2a | For Injection | 103145 | 06/04/1986 | ⤷ Try a Trial | 2034-09-12 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |